TGFBR2 and Hepatic fibrosis: These evidences suggested that miR-130a-3p could inhibit TGF-β/Smads signaling, at least in part, via TGFBR1 and TGFBR2 to affect the activation of HSCs and the phenotype of macrophages involving the development of liver fibrosis.